Nuveen Asset Management, LLC Moderna, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 806,294 shares of MRNA stock, worth $95.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

806,294

Previous 920,649 12.42%

Holding current value

$95.7 Million

Previous $91.6 Million 6.16%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $9.76 Million - $13.2 Million	-114,355 Reduced 12.42%	806,294 $85.9 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $2.67 Million - $4.01 Million	-38,413 Reduced 4.01%	920,649 $91.6 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $998,036 - $1.31 Million	-10,352 Reduced 1.07%	959,062 $99.1 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $5.7 Million - $7.72 Million	-48,081 Reduced 4.73%	969,414 $118 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $1.62 Million - $2.36 Million	-11,978 Reduced 1.16%	1,017,495 $156 Million

Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $11.1 Million - $19.6 Million	93,423 Added 9.98%	1,029,473 $185 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $7.3 Million - $12 Million	-61,815 Reduced 6.19%	936,050 $111 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $8.19 Million - $12.3 Million	-69,932 Reduced 6.55%	997,865 $143 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.61 Million - $3 Million	-12,767 Reduced 1.18%	1,067,797 $187 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $43.3 Million - $70.7 Million	-191,840 Reduced 15.08%	1,080,564 $274 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $46 Million - $100 Million	-207,313 Reduced 14.01%	1,272,404 $490 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $38.7 Million - $70 Million	298,009 Added 25.22%	1,479,717 $348 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $18.1 Million - $30.8 Million	-165,428 Reduced 12.28%	1,181,708 $155 Million
Q4 2020 May 17, 2021	BUY	$65.74 - $169.86 $780,662 - $2.02 Million	11,875 Added 0.89%	1,347,136 $141 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $37.2 Million - $96 Million	565,374 Added 73.44%	1,335,261 $139 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $16.3 Million - $28.4 Million	-299,121 Reduced 27.98%	769,887 $54.5 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $7.6 Million - $20.5 Million	256,011 Added 31.49%	1,069,008 $68.6 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $1.6 Million - $2.84 Million	89,937 Added 12.44%	812,997 $24.3 Million
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $204,088 - $311,773	-14,651 Reduced 1.99%	723,060 $13.8 Million
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $7.9 Million - $11.6 Million	643,967 Added 686.94%	737,711 $11.7 Million
Q2 2019 Aug 15, 2019	BUY	$13.7 - $28.34 $1.28 Million - $2.66 Million	93,744 New	93,744 $1.37 Million

Others Institutions Holding MRNA

# of Institutions

1,036

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Moderna, Inc. Transaction History